Cancer tumour on ovarian wall
Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- Nucala (mepolizumab) is the first treatment to show a significant reduction in flares for patients with Hypereosinophilic Syndrome (HES)
- EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV
- GSK delivers sales of £9.4 billion +16% AER, +11% CER (Pro-forma +6% CER*)
Tweets from GSK
-
GSK @GSK
We’re proud to be inspiring the next generation of scientists 👩🔬👨🔬 in the possibilities of medicine, as principal sponsor of ‘Medicine: The Wellcome Galleries’ at @sciencemuseumseum
about 3 hours ago -
GSK @GSK
Thanks to @GHTCoalition for recognising the impact great partnerships can have to drive innovation in #globalhealth @WHO @MalariaVaccine at @PATHtweets #EndMalaria twitter.com/GHTCoalition/s…
about 6 hours ago
-
GSK @GSK
“The most important thing that's helped at GSK is a laser focus on digital, data and analytics on the reinvention of drug discovery.” Karenann Terrell, our Chief Digital and Technology Officer, speaking at #FTPharma on our approach to technology and digital transformation at GSK.
about 1 day ago
